CHAMPIONS ONCOLOGY, INC.
CSBRChampions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 1 past
No catalysts found.
How CSBR's past catalysts played out
No drugs found in this phase.
Frequently asked questions
When is CHAMPIONS ONCOLOGY, INC.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for CHAMPIONS ONCOLOGY, INC. (CSBR) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track CSBR biotech catalysts?→
Add CSBR to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow CHAMPIONS ONCOLOGY, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.